Article info

Protocol
Efficacy and safety of exogenous surfactant therapy in patients under 12 months of age invasively ventilated for severe bronchiolitis (SURFABRON): protocol for a multicentre, randomised, double-blind, controlled, non-profit trial

Authors

  1. Correspondence to Dr Paolo Biban; paolo.biban{at}aovr.veneto.it
View Full Text

Citation

Biban P, Conti G, Wolfler AM, et al
Efficacy and safety of exogenous surfactant therapy in patients under 12 months of age invasively ventilated for severe bronchiolitis (SURFABRON): protocol for a multicentre, randomised, double-blind, controlled, non-profit trial

Publication history

  • Received March 24, 2020
  • Revised June 6, 2020
  • Accepted August 5, 2020
  • First published October 19, 2020.
Online issue publication 
October 19, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.